XML 13 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2022
Mar. 23, 2023
Jun. 30, 2022
Document Information Line Items      
Entity Registrant Name SILO PHARMA, INC    
Trading Symbol SILO    
Document Type 10-K    
Current Fiscal Year End Date --12-31    
Entity Common Stock, Shares Outstanding   3,158,797  
Entity Public Float     $ 10,083,771
Amendment Flag false    
Entity Central Index Key 0001514183    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Well-known Seasoned Issuer No    
Document Period End Date Dec. 31, 2022    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
ICFR Auditor Attestation Flag false    
Document Annual Report true    
Document Transition Report false    
Entity File Number 001-41512    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 27-3046338    
Entity Address, Address Line One 560 Sylvan Avenue    
Entity Address, Address Line Two Suite 3160    
Entity Address, City or Town Englewood Cliffs    
Entity Address, State or Province NJ    
Entity Address, Postal Zip Code 07632    
City Area Code (718)    
Local Phone Number 400-9031    
Title of 12(b) Security Common Stock, $0.0001 par value per share    
Security Exchange Name NASDAQ    
Entity Interactive Data Current Yes    
Auditor Firm ID 106    
Auditor Name Salberg & Company, P.A.    
Auditor Location Boca Raton, Florida